glp 1 oral medication GLP-1s rapidly expanding user base Why GLP-1 Weight-Loss Drugs Are
Description
Jensterle M, Janez A, Fliers E, et al
10.1097/00041433-199802000-00008 Curr Opin Lipidol
Broader Metabolic Health: Research indicates potential benefits for other conditions linked to metabolic dysfunction, such as non-alcoholic fatty liver disease (NAFLD) and polycystic ovary syndrome (PCOS), by improving insulin sensitivity and reducing inflammation
Implications for reduction of gastric motility on other medications Slowing down the movement of the stomach (gastric motility) can have implications for the absorption and onset of action of certain drugs, potentially influencing their effectiveness and safety
